A DEEP INSIGHT TO NEUROLOGICAL ABNORMALITIES IN COVID – 19: A REVIEW
Journal of Disease and Global Health,
An ongoing endemic in the China city of Wuhan in the year 2019, December developed a new strain of (SARS-CoV-2) termed Coronavirus 2 similar to SARS CoV. The emergence of this is not yet known so this endemic seems to be related to severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS-CoV) that are recognised to attack our respiratory system. After the increasing number of cases within the entire planet, World Health Organization revealed SARS-CoV-2 as the epidemic on March 11, 2020. It is seen that the novel virus has affected 140,780,297 people with nearly 3,015,798 deaths across the globe. Some people experience mild to moderate symptoms whereas some fall seriously ill. The infected patients show signs like dry cough, fatigue and fever. Apart from this smell and taste loss was also observed in nearly 70% patients. Hence, neurological manifestations have been observed during covid conditions.
How to Cite
Li Y, Ren Y, Kang J, Zhang Y, He H, Liu W, Zhang Z. Zhonghua wei zhong bing ji jiu yi xue. 2020;32(10):1178–1182.
Zhou Y, Zhang Z, Tian J, Xiong S. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus. Annals of Palliative Medicine. 2020;9(2):428–436.
Parasher A. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgraduate Medical Journal. 2021;97(1147):312–320.
Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: A literature review. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia. 2020; 77:8–12.
Coolen T, Lolli V, Sadeghi N, Rovai A, Trotta N, Taccone FS, Creteur J, Henrard S, Goffard JC, Dewitte O, Naeije G, Goldman S, De Tiège X. Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. 2020; 95(14):e2016–e2027.
Galassi G, Marchioni A. Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barré syndrome. mActa neurologica Belgica. 2020; 120(5):1067–1075. Available:https://doi.org/10.1007/s13760-020-01421-3
Xie M, Chen Q. Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases. 2020;94:119–124.
Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: A review. JAMA neurology. 2020;77(8):1018–1027.
Amato A, Caggiano M, Amato M, Moccia G, Capunzo M, De Caro F. Infection control in dental practice during the COVID-19 Pandemic. International Journal of Environmental Research and Public Health. 2020;17(13):4769. Available:https://doi.org/10.3390/ijerph17134769
Karimi-Galougahi M, Yousefi-Koma A, Bakhshayeshkaram M, Raad N, Haseli S. 18FDG PET/CT Scan Reveals Hypoactive Orbitofrontal Cortex in Anosmia of COVID-19. Academic Radiology. 2020;27(7):1042–1043.
Vonck K, Garrez I, De Herdt V, Hemelsoet D, Laureys G, Raedt R, Boon P. Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2. European journal of neurology. 2020;27(8):1578–1587.
Rajapakse N, Dixit D. Human and novel coronavirus infections in children: a review. Paediatrics and international child health. 2021;41(1):36–55.
Rudan I, Adeloye D, Katikireddi SV, Murray J, Simpson C, Shah SA, Robertson C, Sheikh A, EAVE II collaboration. The COVID-19 pandemic in children and young people during 2020-2021: Learning about clinical presentation, patterns of spread, viral load, diagnosis and treatment. Journal of Global Health. 2021;11:01010.
Yüce M, Filiztekin E, Özkaya KG. COVID-19 diagnosis -A review of current methods. Biosensors & bioelectronics. 2021;172:112752.
Mahshid SS, Flynn SE, Mahshid S. The potential application of electrochemical biosensors in the COVID-19 pandemic: A perspective on the rapid diagnostics of SARS-CoV-2. Biosensors & bioelectronics. 2021; 176:112905.
Kikkert M. Innate Immune Evasion by Human Respiratory RNA Viruses. Journal of Innate Immunity. 2020;12(1):4–20.
Galmiche S, Bruel T, Madec Y, Tondeur L, Grzelak L, Staropoli I, Fontanet A. Characteristics associated with olfactory and taste disorders in COVID-19. Neuroepidemiology. 2020;55(5):381-386.
Nersesjan V, Amiri M, Lebech AM, Roed C, Mens H, Russell L, ..Kondziella D. Central and peripheral nervous system complications of COVID-19: A prospective tertiary center cohort with 3-month follow-up. Journal of Neurology. 2021;268(9):3086-3104.
Chigr F, Merzouki M, Najimi M. Comment on The neuroinvasive potential of SARS‐CoV‐2 may play a role in the respiratory failure of COVID‐19 patients. Journal of Medical Virology. 2020;92(7):703-704.
Li K, Wohlford-Lenane C, Perlman S, Zhao J, Jewell AK, Reznikov LR, McCray Jr PB. Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. The Journal of infectious diseases. 2016;213(5):712-722.
Zhang Y, Dai C, Wang H, Gao Y, Li T, Fang Y. Li M. Analysis and validation of a highly sensitive one-step nested quantitative real-time polymerase chain reaction assay for specific detection of severe acute respiratory syndrome coronavirus 2. Virology Journal. 2020;17(1):1-13.
Spence JD, De Freitas GR, Pettigrew LC, Ay H, Liebeskind DS, Kase CS. Venketasubramanian N. Mechanisms of stroke in COVID-19. Cerebrovascular Diseases. 2020;49(4):451-458.
Wang Z, Yang Y, Liang X, Gao B, Liu M, Li W, Wang Z. COVID-19 associated ischemic stroke and hemorrhagic stroke: incidence, potential pathological mechanism, and management. Frontiers in Neurology. 2020;11:571996.
Baig AM, Sanders EC. Potential neuroinvasive pathways of SARS‐CoV‐2: Deciphering the spectrum of neurological deficit seen in coronavirus disease‐2019 (COVID‐19). Journal of medical virology. 2020;92(10): 1845-1857.
Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen Á, Layos-Romero A, García-García J, Segura T. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020;95(8):e1060-e1070.
Heidari F, Karimi E, Firouzifar M, Khamushian P, Ansari R, Ardehali MM, Heidari F. Anosmia as a prominent symptom of COVID-19 infection. Rhinology. 2020; 58(3):302-303.
Das L, Dutta P, Walia R, Mukherjee S, Suri V, Puri GD, Bhansali A. Spectrum of endocrine dysfunction and association with disease severity in patients with COVID-19: insights from a cross-sectional, observational study. Frontiers in Endocrinology. 2021;12.
Rani I, Goyal A, Bhatnagar M, Manhas S, Goel P, Pal A, Prasad R. Potential molecular mechanisms of zinc-and copper-mediated antiviral activity on COVID-19. Nutrition Research. 2021;92:109-128.
Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020;12(4):372.
Abstract View: 21 times
PDF Download: 2 times